$CBAY CymaBay Therapeutics, Inc. Insider Trading


Get free email notifications about insider trading in CymaBay Therapeutics, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of insider trading in CymaBay Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in CymaBay Therapeutics, Inc. for free.

CIK Number: 0001042074
IRS Number: 943103561
Trading Symbol: CBAY
Company Address: 7575 GATEWAY BOULEVARD SUITE 110 NEWARK 94560
Phone number: 510-293-8800
Former name: METABOLEX INC, date of change: 1997-07-10

CymaBay Therapeutics, Inc. is a clinical stage biopharmaceutical company, focused on developing and providing access to therapies for patients with liver and other chronic diseases with high unmet medical need. Its products include MBX-8025 and Arhalofenate, MBX-8025 aims to treat lipid and liver diseases while Arhalofenate intends to reduce gout flares and serum uric acid. The company was founded on October 5, 1988 and is headquartered in Newark, CA.

Market Capitalization: $52.52M
Prev close: $2.05
Average Daily Volume: 363,679
Days Low: $2.01
Year Low: $0.82
Year High: $3.04

CymaBay Therapeutics, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 08 2019CBAYCymaBay Therapeuti ...GOLDFISCHER CARLDirectorOption ExerciseM5.509,34051,3700
Feb 08 2019CBAYCymaBay Therapeuti ...GOLDFISCHER CARLDirectorOption ExerciseM5.002,33511,6750
Feb 08 2019CBAYCymaBay Therapeuti ...GOLDFISCHER CARLDirectorSellS9.0211,675105,328011.7 K to 0 (-100.00 %)
Feb 08 2019CBAYCymaBay Therapeuti ...GOLDFISCHER CARLDirectorBuyM5.509,34051,37011,6752.3 K to 11.7 K (+400.00 %)
Feb 08 2019CBAYCymaBay Therapeuti ...GOLDFISCHER CARLDirectorBuyM5.002,33511,6752,3350 to 2.3 K
Jan 31 2019CBAYCymaBay Therapeuti ...Menold DanielVice President, Fin ...Option ExerciseA8.4369,156582,98569,156
Jan 31 2019CBAYCymaBay Therapeuti ...Dickinson KlaraChief Regulatory Of ...Option ExerciseA8.43138,3121,165,970138,312
Jan 31 2019CBAYCymaBay Therapeuti ...Quinlan Paul TGeneral CounselOption ExerciseA8.4386,445728,73186,445
Jan 31 2019CBAYCymaBay Therapeuti ...Boudes Pol FChief Medical Offic ...Option ExerciseA8.43138,3121,165,970138,312
Jan 31 2019CBAYCymaBay Therapeuti ...McWherter CharlesChief Science Offic ...Option ExerciseA8.43172,8911,457,471172,891
Jan 31 2019CBAYCymaBay Therapeuti ...Shah SujalChief Executive Off ...Option ExerciseA8.43328,4922,769,188328,492
Jan 31 2019CBAYCymaBay Therapeuti ...Wills Robert JamesDirectorOption ExerciseA8.4327,705233,55327,705
Jan 31 2019CBAYCymaBay Therapeuti ...Weiland Robert J.DirectorOption ExerciseA8.4327,705233,55327,705
Jan 31 2019CBAYCymaBay Therapeuti ...TRUEX PAUL FDirectorOption ExerciseA8.4327,705233,55327,705
Jan 31 2019CBAYCymaBay Therapeuti ...STEIN EVAN A.DirectorOption ExerciseA8.4327,705233,55327,705

View all CymaBay Therapeutics, Inc. insider transactions.